Completed
Pharmacological Modulation of Cocaine Effects
What is being tested
Data Collection
Who is being recruted
Mental Disorders+1
+ Substance-Related Disorders
+ Cocaine-Related Disorders
How is the trial designed
Treatment Study
Phase 2
Interventional
Summary
Principal SponsorNational Institute on Drug Abuse (NIDA)
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.
Official TitlePharmacological Modulation of Cocaine Effects
Principal SponsorNational Institute on Drug Abuse (NIDA)
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Female
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Mental DisordersSubstance-Related DisordersCocaine-Related DisordersChemically-Induced Disorders
Criteria
Please contact site for information.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Suspended
Johns Hopkins University (BPRU) Bayview Campus
Baltimore, United StatesOpen Johns Hopkins University (BPRU) Bayview Campus in Google MapsCompletedOne Study Center